StocksFin Logo
BMRN logo
$BMRN

BioMarin Pharmaceutical Inc.

BMRN country of incorporation
|
https://www.biomarin.com
|
Mr. Jean-Jacques Bienaime
|
3,045 employees
NASDAQ | Healthcare | Biotechnology
BMRN reported its Q322 earnings on October 28, 2022 (99 weeks ago).
$505.34M 23.6% vs. Q321 Revenues Q322
76.99% 3.1% vs. Q321 Gross Profit Margin
-1.32% ! 85.3% vs. Q321 Net Profit Margin
121.85M 58.9% vs. Q321 Free Cash Flow Q322
$-0.04 ! 80% vs. Q321 EPS Q322
Company Card Q322
As reported on October 28, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on October 28, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
505.34M
-5.3%
116.29M
-6.65M
-124%
$-0.04
Q22022
533.8M
+2.8%
123.13M
27.66M
-77.1%
$0.15
Q12022
519.36M
116.97M
120.8M
$0.66
FY2021
1.85B
 470.52M
-64.08M
$-0.35
Q42021
449.81M
+10%
119.75M
-57.9M
-58.7%
$-0.32
Q32021
408.74M
-18.5%
103.54M
-36.49M
-382%
$-0.2
Q22021
501.69M
+3.2%
127.06M
12.94M
-25.5%
$0.07
Q12021
486.07M
120.17M
17.37M
$0.1
FY2020
1.86B
 524.27M
859.1M
$4.75
FY2019
1.7B
 359.47M
-23.85M
$-0.13
FY2018
1.49B
 315.26M
-77.21M
$-0.44
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
6.26B
 1.7B
761.52M
1.09B
4.57B
Q22022
6.15B
 1.64B
619.8M
1.09B
4.5B
Q12022
6.06B
 1.67B
605.44M
1.09B
4.39B
FY2021
6B
 1.73B
587.28M
1.1B
4.27B
FY2020
5.85B
 1.74B
649.16M
1.1B
4.11B
FY2019
4.69B
 1.57B
437.45M
1.23B
3.12B
FY2018
4.43B
 1.46B
493.98M
830.42M
2.97B
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
158.32M
 -23.4M
7.54M
-36.47M
121.85M
+332.2%
Q22022
56.23M
 -29.7M
-11.78M
-28.04M
28.19M
+137%
Q12022
-45.43M
 87.78M
-25.28M
-30.68M
-76.11M
FY2021
304.54M
 -366.31M
-48k
-119.23M
185.31M
FY2020
85.37M
 -53.62M
181.12M
-137.52M
-52.15M
FY2019
48.26M
 -31.03M
-74.67M
-163.41M
-115.14M
FY2018
20.21M
 264.35M
-388.01M
-144.62M
-124.41M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees